| Literature DB >> 31657011 |
Christina Hunger1, Rebecca Hilzinger1, Laura Klewinghaus1, Laura Deusser1, Anja Sander2, Johannes Mander3, Hinrich Bents3, Beate Ditzen1, Jochen Schweitzer1.
Abstract
This randomized controlled trial (RCT) aimed to pilot the newly developed manualized and monitored systemic therapy (ST) for social anxiety disorder (SAD), as compared to manualized and monitored cognitive behavioral therapy (CBT). We conducted a prospective multicenter, assessor-blind pilot RCT on 38 outpatients (ICD F40.1; Structured Clinical Interview for DSM (SCID); Liebowitz Social Anxiety Scale, LSAS-SR >30). The primary outcome was level of social anxiety (LSAS-SR) at the end of treatment. A total of 252 persons were screened, and 38 patients were randomized and started therapy (CBT: 20 patients; ST: 18 patients; age: M = 36 years, SD = 14). Within-group, simple-effect intent-to-treat analyses (ITT) showed significant reduction in LSAS-SR (CBT:d = 1.04; ST:d = 1.67), while ITT mixed-design ANOVA demonstrated the advantage of ST (d = 0.81). Per-protocol analyses supported these results. Remission based on reliable change indices also demonstrated significant difference (LSAS-SR: 15% in CBT; 39% in ST;h: 0.550), supported by blind diagnosticians' ratings of those who completed therapy (SCID; 45% in CBT, 78% in ST,p = .083). No adverse events were reported. CBT and ST both reduced social anxiety, supporting patient improvement with the newly developed ST for SAD; this has yet to be verified in a subsequent confirmatory RCT.Entities:
Keywords: Adherence; Cognitive Behavioral Therapy; Functioning; Individual; Manual; Monitoring; Randomized Controlled Trial; Social Anxiety; Social Phobia; Social System; Systemic Therapy; cumplimiento; ensayo controlado aleatorizado; manual; terapia cognitivo-conductual; terapia sistémica; trastorno de ansiedad social; 坚守; 指南; 社交恐惧症; 系统治疗; 认知行为治疗; 随机控制试验
Year: 2019 PMID: 31657011 DOI: 10.1111/famp.12492
Source DB: PubMed Journal: Fam Process ISSN: 0014-7370